IL17F and breast cancer: Increased Th17 lymphocytes concentration, via the secretion of IL-17F cytokine, which activates the MAPK signaling pathway in BC cells, leads to the unregulated expression of the pro-tumor genes, which finally accelerates tumor progression [58].